Details for New Drug Application (NDA): 018580
✉ Email this page to a colleague
The generic ingredient in YUTOPAR is ritodrine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the ritodrine hydrochloride profile page.
Summary for 018580
Tradename: | YUTOPAR |
Applicant: | Astrazeneca |
Ingredient: | ritodrine hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018580
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 15MG/ML | ||||
Approval Date: | Sep 27, 1984 | TE: | RLD: | No |
Expired US Patents for NDA 018580
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-002 | Sep 27, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription